primary hypertension
Conditions
Interventions
Sponsors
Qinzhou First People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years old, male or female; 2. According to the diagnostic criteria of the Chinese guidelines for the prevention and treatment of hypertension (2018 revision), the diagnosis is primary Hypertension; 3. Have taken bevanolol hydrochloride tablets before or plan to take bevanolol hydrochloride tablets; 4. Voluntarily participate and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Those who have a history of allergies or contraindications to the research drugs and excipients; 2. History of chronic diseases or serious diseases such as liver and kidney; 3. Patients with severe cerebrovascular disease within 6 months before enrollment in this trial; 4. Pregnant and lactating women; 5. The researcher believes that it is not suitable to participate in this researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of sitting diastolic blood pressure relative to baseline value after administration; | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of sitting systolic blood pressure relative to baseline value after administration;Effective rate of hypotension after medication;Changes in heart rate after medication; | — |
Countries
China
Contacts
Public ContactGeng Dan
Qinzhou First People's Hospital
Outcome results
None listed